Fear of recurrence in long-term testicular cancer survivors

Psycho-Oncology

Volumn 18, Issue 6, 2009, Pages 580-588

  Skaali, Tone ^a,b   Fosså, Sophie D ^a,b   Bremnes, Roy ^c   Dahl, Olav ^d   Haaland, Carl Fredrik ^e   Hauge, Erik Rønneberg ^f   Klepp, Olbjörn ^g   Oldenburg, Jan ^a,b   Wist, Erik ^e   Dahl, Alv A ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^e ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^f NKS Olaviken Hospital for Old Age Psychiatry   (Norway)

^g NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Anxiety; Cancer; Fear of recurrence; Oncology; Testicular cancer survivor

Indexed keywords

ADULT; AGED; ARTICLE; ATTITUDE TO ILLNESS; CANCER RECURRENCE; CANCER SURVIVOR; CONTROLLED STUDY; COPING BEHAVIOR; DISTRESS SYNDROME; EDUCATIONAL STATUS; FATIGUE; FEAR; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROSIS; PATIENT ATTITUDE; PSYCHOLOGICAL RATING SCALE; QUALITY OF LIFE; SELF ESTEEM; SOCIAL ADAPTATION; STRUCTURED INTERVIEW; TESTIS CANCER;

ADAPTATION, PSYCHOLOGICAL; ADULT; CROSS-SECTIONAL STUDIES; DEFENSE MECHANISMS; FATIGUE; FEAR; FOLLOW-UP STUDIES; GERMINOMA; HEALTH BEHAVIOR; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEUROTIC DISORDERS; PERSONALITY INVENTORY; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS; SELF CONCEPT; SEMINOMA; SICK ROLE; SOCIOECONOMIC FACTORS; SURVIVORS; TESTICULAR NEOPLASMS;

EID: 67949099056     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.1437     Document Type: Article

References (47)

1. Lee-Jones C, Humphris G, Dixon R et al. Fear of cancer recurrence - a literature review and proposed cognitive formulation to explain exacerbation of recurrence fears. Psycho-Oncol 1997; 6:95-105.
2. Lance Armstrong Foundation: Emotional effects fear of recurrence. (Available from: http://www.livestrong.org/site/c.khLXK1PxHmF/b.2660669/ [cited2008 06.10].)
3. Wickberg SMJ. The Concerns About Recurrence Scale [CARS]: a systematic measure of women's fears about the possibility of breast cancer recurrence. Ann Behav Med 2003;25:16-24.
4. van den Beuken-van Everdingen MH, Peters ML, de Rijke JM et al. Concerns of former breast cancer patients about disease recurrence: a validation and prevalence study. Psycho-Oncol 2008 (e-pub) DOI 10.1002/pon.1340.
5. Stanton AL, Danoff-Burg S, Huggins ME. The first year after breast cancer diagnosis: hope and coping strategies as predictors of adjustment. Psycho-Oncol 2002;11: 83-102.
6. Hodkinson K, Butow P, Fuchs A et al. Long-term survival from gynecologic cancer: psychosocial outcomes, supportive care needs and positive outcomes. Gynecol Oncol 2007;104:381-389.
7. Mehta SS, Lubeck DP, Pasta DJ et al. Fear of cancer recurrence in patients undergoing definitive treatment for prostate cancer: results from CaPSURE. J Urol 2003;170:1931-1933.
8. Hart SL, Latini DM, Cowan JE et al. Fear of recurrence, treatment satisfaction, and quality of life after radical prostatectomy for prostate cancer. Support Care Cancer 2008;16:161-169.
9. Bellizzi KM, Latini DM, Cowan JE et al. Fear of recurrence, symptom burden, and health-related quality of life in men with prostate cancer. Urology 2008 (e-pub) DOI 10.1016/j.urology.2007.12.084.
10. Simard S, Savard J. Fear of cancer recurrence inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer 2008 April 15 (e-pub) DOI 10.1007/ s00520-008-0444-y.
11. Mullens AB, McCaul KD, Erickson SC et al. Coping after cancer: risk perceptions, worry and health behaviors among colorectal cancer survivors. Psycho-Oncol 2004;13:367-376.
12. Mellon S, Kershak TS, Northouse LL et al. A family-based model to predict fear of recurrence for cancer survivors and their caregivers. Psycho-Oncol 2007;3: 214-223.
13. Humphris GM, Rogers S, McNally D et al. Fear of recurrence and possible cases of anxiety and depression in orofacial cancer patients. Int J Oral Maxillofac Surg 2003;32:486-491.
14. Black EK, White CA. Fear or recurrence, sense of coherence and posttraumatic stress disorder in haematological cancer survivors. Psycho-Oncol 2005;14: 510-515.
15. Young KE, White CA. The prevalence and moderators of fatigue in people who have successfully treated for cancer. J Psychosom Res 2006; 60:29-38.
16. Humphris G, Ozakinci G. The AFTER intervention: a structured psychological approach to reduce fears of recurrence in patients with head and neck cancer. Br J Health Psychol 2008;13:223-230.
17. Verdecchia A, Francisci S, Brenner H, et al. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol 2007;8: 784-796.
18. Oldenburg J, Martin JM, Fosså SD. Late relapses of germ cell malignancies: incidence, management, and prognosis. J Clin Oncol 2006;24:5503-5511.
19. Oldenburg J, Alfsen GC, Wćhre H, et al. Late recurrences of germ cell malignancies: a population-based experience over three decades. Br J Cancer 2006;94:820-827.
20. Jones GY, Payne S. Searching for safety signals: the experience of medical surveillance amongst men with testicular teratomas. Psycho-Oncol 2000;9: 385-394.
21. Dahl AA, Mykletun A, Fosså SD. Quality of life in survivors of testicular cancer. Urol Oncol 2005;23: 193-200.
22. Moynihan C. Testicular cancer: the psychosocial problems of patients and their relatives. Cancer Surv 1987;6:477-510.
23. Dahl AA, Haaland CF, Mykletun A, et al. Study of anxiety disorder and depression in long-term survivors of testicular cancer. J Clin Oncol 2005;10: 2389-2395.
24. Oldenburg J, Fossao SD, Dahl AA. Scale for Chemotherapy-Induced Long-Term Neurotoxicity [SCIN]: psychometrics, validation, and findings in a large sample of testicular cancer survivors. Qual Life Res 2006;15: 791-800.
25. Aasland OG, Amundsen A, Bovim G, et al. Identification of patients at risk of alcohol related damage [article in Norwegian]. Tidsskr Nor Laegeforen 1990;110: 1523-1527.
26. Thorsen L, Nystad W, Stigum H, et al. The association between self-reported physical activity and prevalence of depression and anxiety in long-term survivors of testicular cancer and in general population sample. Support Care Cancer 2005;13:637-646.
27. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression scale. Acta Psychiatr Scand 1983;67: 361-370.
28. Bjelland I, Dahl AA, Haug TT, et al. The validity of The Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res 2002;52:69-77.
29. Chalder T, Berelowitz G, Pawlikowska T, et al. Development of a fatigue scale. J Psychosom Res 1993;37:147-153.
30. Horowitz M, Wilner N, Alvarez W. Impact of Event Scale: a measure of subjective stress. Psychosom Med 1979;41:209-218.
31. Sundin EC, Horowitz MJ. Impact of Event Scale: psychometric properties. Br J Psychiatry 2002;180: 205-209.
32. Sundin EC, Horowitz MJ. Horowitz's Impact of Event Scale evaluation of 20 years of use. Psychosom Med 2003;65:870-876.
33. Ware JEJ, Snow KK, Kosinski M, Gandek B. SF-36® Health Survey: Manual and Interpretation Guide. QualityMetric Inc.: Lincoln, RI, 2000.
34. Ware JEJ, Kosinski M, Keller SD. SF-36® Physical and Mental Health Summary Scales: A User's Manual. The Health Institute: Boston, MA, 1994.
35. Watson D, Gamez W, Simms LJ. Basic dimensions of temperament and their relation to anxiety and depression: a symptom-based perspective. J Res Pers 2005;39: 46-66.
36. Weinstock LM, Whisman MA. Neuroticism as a common feature of the depressive and anxiety disorders: a test of the revised integrative hierarchical model in a national sample. J Abnorm Psychol 2006; 115: 68-74.
37. Eysenck HJ, Eysenck SBG. Manual of the EPQ. Hodder and Stoughton: London, 1975.
38. Eysenck SBG, Eysenck HJ, Barrett P. A revised version of the Psychoticism Scale. Pers Individ Differences 1985;6:21-29.
39. Eysenck SBG, Tambs K. Cross-cultural comparison of personality: Norway and England. Scand J Psychol 1990;31:191-197.
40. Rosenberg M. Society and the Adolescent Self-Image. Princeton University Press: New Jersey, 1965.
41. Tambs K. Moderate effects of hearing loss on mental health and subjective well-being: results from the Nord-Trøndelag Hearing Loss Study. Psychosom Med 2004;66:776-782.
42. Finset A, Steine S, Haugli L et al. The Brief Approach/Avoidance Coping Questionnaire: development and validation. Psychol Health Med 2002;7:75-85.
43. Sheehan DV, Lecrubier Y, Sheehan KH et al. The Mini International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(suppl. 20):22-33.
44. Sheehan DV, Lecrubier Y, Harnett Sheehan K et al. The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. Eur Psychiatry 1997; 12:232-241.
45. Norusis M. Ordinal Regression. In SPSS 16.0 Advanced Statistical Procedures Companion. Prentice-Hall: Upper Saddle River, NJ, 2008; 69-89.
46. Fleer J, Sleijfer D, Hoekstra H et al. Objective and subjective predictors of cancer-related stress symptoms in testicular cancer survivors. Patient Educ Couns 2006;64:142-150.
47. Sørlie T, Rosenvinge JH, Bremnes R et al. Management satisfaction in survivors of testicular cancer. Anticancer Res 2006;26:1463-1469.